Novartis stock has investor call on October 23 ahead of Xetra open
Published on 10/21/2026 at 08:32 | Editorial responsibility: Rafael Müller, Editor-in-Chief AD HOC NEWSInvestor events before results
- Novartis AG lists a Remibrutinib in MS investor call for October 23, 2026.
- Third-quarter results are scheduled for October 27, 2026.
- Novartis stock trades pre-market at EUR 136.80 at 8:31 a.m. CEST at Lang & Schwarz on October 21, 2026.
Novartis AG lists a Remibrutinib in multiple sclerosis investor call for October 23, 2026, on its investor calendar. At 8:31 a.m. CEST on October 21, 2026, Novartis stock was at EUR 136.80 at Lang & Schwarz. The event information is published by Novartis.
Investor events on the calendar
The company’s investor calendar identifies the Remibrutinib in MS event as an online investor call. Novartis also lists its third-quarter results for October 27, 2026, with a webcast scheduled for 8:00 a.m. EDT. Both dates appear on the company’s investor-relations page.
Ahead of the Xetra open
Lang & Schwarz recorded the pre-market indication for the October 21, 2026 trading day. The further course from the Xetra open at 9:00 a.m. CEST is shown by the continuously updated real-time quote of Novartis stock.
Medicines and upcoming events
Novartis describes its business as reimagining medicine to improve and extend people’s lives. The company’s next listed event is the October 23 investor call, followed by third-quarter results on October 27. Market context: Market report SMI.
